Exploring the causal association between circulating leukocyte count and IgA nephropathy based on two-sample Mendelian randomization: possible role of transitional B cells.
{"title":"Exploring the causal association between circulating leukocyte count and IgA nephropathy based on two-sample Mendelian randomization: possible role of transitional B cells.","authors":"Fang Fang, Hong Wang, Jun Luo, Fatong Hong","doi":"10.1007/s10157-025-02646-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To examine the causal association between genetically predicted circulating leukocyte counts and IgA nephropathy.</p><p><strong>Methods: </strong>A two-sample Mendelian randomization (MR) design was used. The exposures were the neutrophil, lymphocyte (with subsequent analyses for memory B-cell %lymphocyte, IgD<sup>-</sup> CD38<sup>br</sup> %lymphocyte, IgD<sup>+</sup> CD38<sup>br</sup> %lymphocyte, CD24<sup>+</sup> CD27<sup>+</sup> %lymphocyte, Sw mem %lymphocyte, transitional %lymphocyte, and naïve-mature B-cell %lymphocyte), monocyte, basophil, and eosinophil counts. The outcome was IgA nephropathy. Analysis was conducted using the inverse variance weighted (IVW), MR-Egger, weighted median, and weighted mode. The Cochran's Q-test and MR-Egger regression were used to assess heterogeneity and horizontal pleiotropy, respectively. The robustness of the results was tested using MR-PRESSO and leave-one-out analyses.</p><p><strong>Results: </strong>The genetic prediction results showed causal associations between the neutrophil counts and IgA nephropathy (OR = 2.62, 95%CI 2.47-2.77, P < 0.001) and between the lymphocyte counts and IgA nephropathy (OR = 0.76, 95%CI 0.58-0.99, P = 0.04). Monocyte, basophil, and eosinophil counts showed no causal associations with IgA nephropathy. The supplementary genetic prediction analyses showed a causal association between transitional %lymphocytes and IgA nephropathy (OR = 0.58, 95%CI 0.39-0.87, P = 0.008). Cochran's Q test revealed heterogeneity for the neutrophil, lymphocyte, monocyte, eosinophil, transitional %lymphocytes, and count analyses (all P < 0.05), but the MR-Egger test revealed no pleiotropy. After removing the outliers, the associations remained the same.</p><p><strong>Conclusion: </strong>Causal associations were observed between neutrophil and lymphocyte counts as exposures and IgA nephropathy as outcome. Among lymphocytes, transitional B cells could be involved in the pathogenesis of IgA nephropathy. Attention should be paid to neutrophil and lymphocyte counts in future studies on IgA nephropathy.</p>","PeriodicalId":10349,"journal":{"name":"Clinical and Experimental Nephrology","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10157-025-02646-3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: To examine the causal association between genetically predicted circulating leukocyte counts and IgA nephropathy.
Methods: A two-sample Mendelian randomization (MR) design was used. The exposures were the neutrophil, lymphocyte (with subsequent analyses for memory B-cell %lymphocyte, IgD- CD38br %lymphocyte, IgD+ CD38br %lymphocyte, CD24+ CD27+ %lymphocyte, Sw mem %lymphocyte, transitional %lymphocyte, and naïve-mature B-cell %lymphocyte), monocyte, basophil, and eosinophil counts. The outcome was IgA nephropathy. Analysis was conducted using the inverse variance weighted (IVW), MR-Egger, weighted median, and weighted mode. The Cochran's Q-test and MR-Egger regression were used to assess heterogeneity and horizontal pleiotropy, respectively. The robustness of the results was tested using MR-PRESSO and leave-one-out analyses.
Results: The genetic prediction results showed causal associations between the neutrophil counts and IgA nephropathy (OR = 2.62, 95%CI 2.47-2.77, P < 0.001) and between the lymphocyte counts and IgA nephropathy (OR = 0.76, 95%CI 0.58-0.99, P = 0.04). Monocyte, basophil, and eosinophil counts showed no causal associations with IgA nephropathy. The supplementary genetic prediction analyses showed a causal association between transitional %lymphocytes and IgA nephropathy (OR = 0.58, 95%CI 0.39-0.87, P = 0.008). Cochran's Q test revealed heterogeneity for the neutrophil, lymphocyte, monocyte, eosinophil, transitional %lymphocytes, and count analyses (all P < 0.05), but the MR-Egger test revealed no pleiotropy. After removing the outliers, the associations remained the same.
Conclusion: Causal associations were observed between neutrophil and lymphocyte counts as exposures and IgA nephropathy as outcome. Among lymphocytes, transitional B cells could be involved in the pathogenesis of IgA nephropathy. Attention should be paid to neutrophil and lymphocyte counts in future studies on IgA nephropathy.
期刊介绍:
Clinical and Experimental Nephrology is a peer-reviewed monthly journal, officially published by the Japanese Society of Nephrology (JSN) to provide an international forum for the discussion of research and issues relating to the study of nephrology. Out of respect for the founders of the JSN, the title of this journal uses the term “nephrology,” a word created and brought into use with the establishment of the JSN (Japanese Journal of Nephrology, Vol. 2, No. 1, 1960). The journal publishes articles on all aspects of nephrology, including basic, experimental, and clinical research, so as to share the latest research findings and ideas not only with members of the JSN, but with all researchers who wish to contribute to a better understanding of recent advances in nephrology. The journal is unique in that it introduces to an international readership original reports from Japan and also the clinical standards discussed and agreed by JSN.